Valerie Malyvanh Jansen is CHIEF MEDICAL OFFICER of Elevation Oncology, Inc.. Currently has a direct ownership of 12,311 shares of ELEV, which is worth approximately $6,647. The most recent transaction as insider was on Feb 15, 2025, when has been sold 5,189 shares (Common Stock) at a price of $0.67 per share, resulting in proceeds of $3,476. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 12.3K
n/a 3M change
n/a 12M change
Total Value Held $6,647

Valerie Malyvanh Jansen Transaction History

Date Transaction Value Shares Traded Shares Held Form
Feb 15 2025
SELL
Payment of exercise price or tax liability
$3,476 $0.67 p/Share
5,189 Reduced 29.65%
12,311 Common Stock
Feb 15 2025
BUY
Exercise of conversion of derivative security
-
17,500 Added 50.0%
17,500 Common Stock

Also insider at

RPHM
Reneo Pharmaceuticals, Inc. Healthcare
VMJ

Valerie Malyvanh Jansen

CHIEF MEDICAL OFFICER
New York, NY

Track Institutional and Insider Activities on ELEV

Follow Elevation Oncology, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ELEV shares.

Notify only if

Insider Trading

Get notified when an Elevation Oncology, Inc. insider buys or sells ELEV shares.

Notify only if

News

Receive news related to Elevation Oncology, Inc.

Track Activities on ELEV